Atlas Trials

The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial

Clinical trial NCT06946901 · RECRUITING

Trial details

NCT number
NCT06946901
Sponsor
Shanghai Zhongshan Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hyperthermic Intraperitoneal ChemotherapyPeritoneal Metastatic Pancreatic Cancer
Start date
2025-04-03
Primary completion
2026-04-03
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.